Findings

What do systematic reviews say?

3 questions · 3 findings · 1 reviews · Anaesthesia

Sort:Best matchNewest Highest certainty Download CSV

No studies found 2 · 66.7%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 1 · 33.3%High 0 · 0%

Closest answers

The findings closest to your search, judged one by one by TypeSafe's Jev model.

Related · question page
- Sugammadex 2.0 mg/kg vs neostigmine 0.05 mg/kg · Recovery timea from second twitch (T2) to train‐of‐four ratio (TOFR) > 0.9 (moderate block)
  Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults 2017 · Cochrane Headline outcomes only
  no estimate extracted
  10 studies · 835 participants
  Moderate
Related · question page
- Sugammadex 4.0 mg/kg vs neostigmine 0.07 mg/kg · Recovery timea from second twitch (T2) to train‐of‐four ratio (TOFR) > 0.9 (moderate block)
  Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found
Related · question page
- Sugammadex (any dose) vs neostigmine (any dose) · Recovery timea from second twitch (T2) to train‐of‐four ratio (TOFR) > 0.9 (moderate block)
  Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Sugammadex 2.0 mg/kg vs neostigmine (any dose)

Recovery timea from second twitch (T2) to train‐of‐four ratio (TOFR) > 0.9 (moderate block) · Adult patients, ASA I‐IV, who received non‐depolarizing NMBAs

1 finding from 1 review

Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults 2017 · Cochrane Headline outcomes only
no estimate extracted
10 studies · 835 participants
Moderate

Sugammadex 4.0 mg/kg vs neostigmine (any dose)

Recovery timea from second twitch (T2) to train‐of‐four ratio (TOFR) > 0.9 (moderate block) · Adult patients, ASA I‐IV, who received non‐depolarizing NMBAs

The review found no eligible studies for this question.

1 finding from 1 review

Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Sugammadex (any dose) vs neostigmine (any dose)

Recovery timea from second twitch (T2) to train‐of‐four ratio (TOFR) > 0.9 (moderate block) · Adult patients, ASA I‐IV, who received non‐depolarizing NMBAs

The review found no eligible studies for this question.

1 finding from 1 review

Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found